ChromaDex Q3 EPS $(0.12), Inline, Sales $12.1M Beat $11.59M Estimate

ChromaDex (NASDAQ:CDXC) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.16) per share from the same period last year. The company

Benzinga · 11/12/2019 21:23

ChromaDex (NASDAQ:CDXC) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $12.1 million which beat the analyst consensus estimate of $11.59 million by 4.40 percent. This is a 49.01 percent increase over sales of $8.12 million the same period last year.